Market Closed -
Other stock markets
|
After market 02:29:28 am | |||
29.49 USD | +0.61% | 29.49 | 0.00% |
02:22pm | Pfizer: article on Lyme vaccine in The Lancet | CF |
12:25pm | Pfizer Partners with Abu Dhabi to Advance Research on Sickle Cell Disease | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.43% | 17TCr | |
+42.83% | 75TCr | |
+34.11% | 60TCr | |
-5.70% | 36TCr | |
+18.06% | 33TCr | |
+4.63% | 28TCr | |
+17.02% | 24TCr | |
+9.26% | 21TCr | |
-4.21% | 21TCr | |
+6.67% | 16TCr |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- FDA Approves Pfizer's CIBNOQ For Adults With Moderate-to-Severe Atopic Dermatitis